Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / RHHBY - Aptose: Cancer Trial Catalyst Ahead At EHA21

RHHBY - Aptose: Cancer Trial Catalyst Ahead At EHA21

Roche Holding Ltd ADR
  • APTO is presenting new data at EHA21 for its Btk inhibitor, Luxeptinib.
  • The data could be a catalyst event (up or down) for this stock.
  • There's a lot of competition for non-covalent Btk inhibitors in blood cancers.

For further details see:

Aptose: Cancer Trial Catalyst Ahead At EHA21
Stock Information
Company Name: Roche Holding Ltd ADR
Stock Symbol: RHHBY
Market: OTC
Website: roche.com
Menu
RHHBY RHHBY Quote RHHBY Short RHHBY News RHHBY Articles RHHBY Message Board
Get RHHBY Alerts

News, Short Squeeze, Breakout and More Instantly...